Etiologic factors in sialolithiasis

Otolaryngology - Head and Neck Surgery

Volumn 145, Issue 6, 2011, Pages 935-939

  Huoh, Kevin C ^a   Eisele, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Salivary stones; Sialolithiasis

Indexed keywords

DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLELITHIASIS; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROLITHIASIS; PAROTID GLAND; RETROSPECTIVE STUDY; SIALOLITHIASIS; SMOKING; SUBMANDIBULAR GLAND; AGE DISTRIBUTION; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RARE DISEASE; RISK FACTOR; SALIVARY GLAND DISEASE; SEX RATIO; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIURETICS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RARE DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVARY GLAND CALCULI; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; UNITED STATES; YOUNG ADULT;

EID: 84856073607     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811415489     Document Type: Article

References (14)

1. Marchal F, Dulguerov P. Sialolithiasis management: the state of the art. Arch Otolaryngol Head Neck Surg. 2003;129(9):951-956. (Pubitemid 37087655)
2. Epivatianos A, Harrison JD, Dimitriou T. Ultrastructural and histochemical observations on microcalculi in chronic submandibular sialadenitis. J Oral Pathol. 1987;16(10):514-517.
3. Harrison JD, Epivatianos A, Bhatia SN. Role of microliths in the aetiology of chronic submandibular sialadenitis: a clinicopathological investigation of 154 cases. Histopathology. 1997;31(3):237-251. (Pubitemid 27397917)
4. Marchal F, Kurt AM, Dulguerov P, Lehmann W. Retrograde theory in sialolithiasis formation. Arch Otolaryngol Head Neck Surg. 2001;127(1):66-68. (Pubitemid 32063989)
5. Harrison JD. Causes, natural history, and incidence of salivary stones and obstructions. Otolaryngol Clin North Am. 2009;42(6):927-947.
6. Williams MF. Sialolithiasis. Otolaryngol Clin North Am. 1999;32(5):819-834. (Pubitemid 29489250)
7. Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 2002;32(3):268-277. (Pubitemid 34126405)
8. Adult Smoking Prevalence: California Tobacco Control Program. California Department of Public Health. March 2010. cdph.ca.gov/programs/Tobacco. Accessed May 10, 2010.
9. Al-Delaimy WK, Messer K, White MM. Volume 3: Methods Used for Final Report. The California Tobacco Control Program: Can We Maintain the Progress? San Diego, CA: California Department of Health Services; June 2007.
10. Miller GE, Doshi A. Statistical Brief #119: Diuretic Use in the Treatment of Hypertension, by Selected Population Characteristics, 2003. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality March; 2006. http://meps.ahrq.gov/mepsweb/data-files/publications/st119/ stat119.shtml. Accessed May 10, 2010.
11. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639. (Pubitemid 29409249)
12. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823. (Pubitemid 36513328)
13. Rogers J, McCaffrey TV. Inflammatory Disorders of the salivary glands. In: Flint PW, Haughey BH, Lund VJ, et al, eds. Cummings Otolaryngology-Head and Neck Surgery: Fifth Edition. Vol 2. 5th ed. Philadelphia: Mosby Elsevier; 2010:1151-1161.
14. Nederfors T, Nauntofte B, Twetman S. Effects of furosemide and bendroflumethiazide on saliva flow rate and composition. Arch Oral Biol. 2004;49(7):507-513. (Pubitemid 38583486)